
Veeral Ajmera
@ajmeraveeral
Hepatologist, Clinical Scientist, Medical Director Of Liver Transplant @UCSD
ID: 1139915707339042816
15-06-2019 15:20:58
23 Tweet
174 Followers
78 Following


How can an assessment of genetic risk be used to impact the clinical management of NAFLD? Read more about the potential value of genetic risk in elucidating disease severity and trajectory. Rohit Loomba Mazen Noureddin, MD, MHSc Michelle T. Long onlinelibrary.wiley.com/doi/10.1111/ap…




The prolific Daniel Huang presenting important data on the association between DM2 and fibrosis progression rates in NAFLD AASLD The Liver Meeting. NAFLD ResearchCenter


Proud of star resident and soon to be UCSD Gastroenterology fellow Kelly Torosian presenting on predictors of biochemical alcohol relapse after LT and uncovering potential disparities in access to transplant. UCSD Internal Medicine Residency Allison Kwong


Lana Bridi, superstar medical student UC San Diego Health, presents our data on applying polygenic risk to stratify patients with T2DM at risk for advanced fibrosis and cirrhosis. NAFLD ResearchCenter Rohit Loomba #TLM2023


Excited for our upcoming UC San Diego Health UCSD Gastroenterology MASLD Research Center Annual Research Symposium on 1/31 focused on management of #obesity & #MASLD. Honored to have Dr. Michael Camilleri & Dr. Elizabeth Speliotes as guest speakers. Still time to register!✍️ See you there!


Thrilled to share that UC San Diego Health Transplant has been recognized as the only 12-bar liver transplant program in Southern California! Excellent pre-transplant survival paired with the highest organ acceptance rate in California and long-term survival among the best in the US.
